Inge Van de Walle, Laura Bracke, Heidi Gytz Olesen, Tonke van Bragt, Stéphanie Cadour, Phillip De Decker, Giorgia Ciurlia, Erwin Pannecoucke, Emma K. Persson, Olivier Van de Steen, Xinghong Leng, Gregers Rom Andersen, Domenica Gandini, C. Erik Hack. "Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart." Nature Communications, 2025. doi:10.1038/s41467-025-62925-1